Quinn Opportunity Partners LLC Sells 329,551 Shares of CVS Health Corporation $CVS

Quinn Opportunity Partners LLC reduced its holdings in shares of CVS Health Corporation (NYSE:CVS) by 68.5% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 151,299 shares of the pharmacy operator’s stock after selling 329,551 shares during the period. CVS Health accounts for approximately 0.9% of Quinn Opportunity Partners LLC’s investment portfolio, making the stock its 25th biggest holding. Quinn Opportunity Partners LLC’s holdings in CVS Health were worth $10,437,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Ballentine Partners LLC lifted its position in shares of CVS Health by 55.4% during the 1st quarter. Ballentine Partners LLC now owns 8,257 shares of the pharmacy operator’s stock valued at $559,000 after acquiring an additional 2,943 shares during the period. Schechter Investment Advisors LLC increased its position in shares of CVS Health by 6.0% during the first quarter. Schechter Investment Advisors LLC now owns 5,945 shares of the pharmacy operator’s stock worth $403,000 after acquiring an additional 336 shares in the last quarter. CWM LLC raised its holdings in shares of CVS Health by 155.2% in the 1st quarter. CWM LLC now owns 103,804 shares of the pharmacy operator’s stock worth $7,033,000 after acquiring an additional 63,121 shares during the last quarter. Bleakley Financial Group LLC boosted its stake in CVS Health by 150.3% during the 1st quarter. Bleakley Financial Group LLC now owns 49,915 shares of the pharmacy operator’s stock valued at $3,382,000 after purchasing an additional 29,975 shares during the last quarter. Finally, Signaturefd LLC raised its stake in shares of CVS Health by 43.6% in the first quarter. Signaturefd LLC now owns 19,923 shares of the pharmacy operator’s stock worth $1,350,000 after purchasing an additional 6,048 shares during the last quarter. Institutional investors own 80.66% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts recently issued reports on CVS shares. Cowen reaffirmed a “buy” rating on shares of CVS Health in a research report on Monday, August 4th. Wall Street Zen lowered shares of CVS Health from a “buy” rating to a “hold” rating in a research note on Saturday, November 1st. Weiss Ratings reissued a “hold (c-)” rating on shares of CVS Health in a research report on Wednesday, November 5th. Evercore ISI boosted their price target on shares of CVS Health from $85.00 to $95.00 and gave the stock an “outperform” rating in a report on Thursday, October 30th. Finally, UBS Group increased their price objective on shares of CVS Health from $79.00 to $96.00 and gave the company a “buy” rating in a research note on Friday, October 24th. Two investment analysts have rated the stock with a Strong Buy rating, twenty-one have assigned a Buy rating and four have assigned a Hold rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $89.45.

Insider Buying and Selling at CVS Health

In related news, Director Anne A. Finucane sold 7,500 shares of the stock in a transaction dated Wednesday, August 20th. The stock was sold at an average price of $71.02, for a total transaction of $532,650.00. Following the sale, the director owned 22,156 shares of the company’s stock, valued at approximately $1,573,519.12. This represents a 25.29% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Company insiders own 1.22% of the company’s stock.

CVS Health Stock Up 2.8%

CVS stock opened at $79.73 on Wednesday. CVS Health Corporation has a fifty-two week low of $43.56 and a fifty-two week high of $85.15. The stock has a fifty day moving average of $77.36 and a 200-day moving average of $69.67. The company has a market capitalization of $101.22 billion, a price-to-earnings ratio of 209.83, a PEG ratio of 0.87 and a beta of 0.60. The company has a debt-to-equity ratio of 0.83, a quick ratio of 0.62 and a current ratio of 0.83.

CVS Health (NYSE:CVS) last issued its earnings results on Wednesday, October 29th. The pharmacy operator reported $1.60 earnings per share for the quarter, topping analysts’ consensus estimates of $1.36 by $0.24. CVS Health had a net margin of 0.12% and a return on equity of 11.45%. The firm had revenue of $102.87 billion during the quarter, compared to analyst estimates of $98.85 billion. During the same quarter last year, the business earned $1.09 earnings per share. The company’s quarterly revenue was up 7.8% on a year-over-year basis. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. As a group, equities research analysts predict that CVS Health Corporation will post 5.89 earnings per share for the current year.

CVS Health Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Monday, November 3rd. Stockholders of record on Thursday, October 23rd were issued a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a dividend yield of 3.3%. The ex-dividend date of this dividend was Thursday, October 23rd. CVS Health’s dividend payout ratio (DPR) is presently 700.00%.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.